ClinicalTrialsFinder

Angioimmunoblastic T-Cell Lymphoma Refractory Clinical Trials in Xuzhou, Jiangsu

1 recruitingXuzhou, Jiangsu, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Tislelizumab , Cyclophosphamide, Mitoxantrone Liposomes, Chidamide, and Prednisone in the Treatment of R/R AITL

Angioimmunoblastic T-Cell Lymphoma RecurrentAngioimmunoblastic T-Cell Lymphoma Refractory
The Affiliated Hospital of Xuzhou Medical University40 enrolled1 locationNCT07058103